학술논문
Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study.
Document Type
journal article
Author
Wechalekar, Ashutosh; Antoni, Gunnar; Al Azzam, Wasfi; Bergström, Mats; Biswas, Swethajit; Chen, Chao; Cheriyan, Joseph; Cleveland, Matthew; Cookson, Louise; Galette, Paul; Janiczek, Robert L.; Kwong, Raymond Y.; Lukas, Mary Ann; Millns, Helen; Richards, Duncan; Schneider, Ian; Solomon, Scott D.; Sörensen, Jens; Storey, James; Thompson, Douglas
Source
BMC Cardiovascular Disorders; 2/13/2022, Vol. 22 Issue 1, p1-16, 16p
Subject
Language
ISSN
14712261
Abstract
Copyright of BMC Cardiovascular Disorders is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)